131 related articles for article (PubMed ID: 7543876)
1. Identification of MIC 11 antigen as an epitope of the CD59 molecule.
Davies A; Wilson AB; Bramley JC; Willers C; Van Heyningen V; Bickmore WA; Lachmann PJ
Immunology; 1995 Jun; 85(2):220-7. PubMed ID: 7543876
[TBL] [Abstract][Full Text] [Related]
2. New monoclonal antibodies in CD59: use for the analysis of peripheral blood cells from paroxysmal nocturnal haemoglobinuria (PNH) patients and for the quantitation of CD59 on normal and decay accelerating factor (DAF)-deficient erythrocytes.
Fletcher A; Bryant JA; Gardner B; Judson PA; Spring FA; Parsons SF; Mallinson G; Anstee DJ
Immunology; 1992 Mar; 75(3):507-12. PubMed ID: 1374058
[TBL] [Abstract][Full Text] [Related]
3. Expression and function of CD59 on colonic adenocarcinoma cells.
Bjørge L; Vedeler CA; Ulvestad E; Matre R
Eur J Immunol; 1994 Jul; 24(7):1597-603. PubMed ID: 7517877
[TBL] [Abstract][Full Text] [Related]
4. Antigen S1, encoded by the MIC1 gene, is characterized as an epitope of human CD59, enabling measurement of mutagen-induced intragenic deletions in the AL cell system.
Wilson AB; Seilly D; Willers C; Vannais DB; McGraw M; Waldren CA; Hei TK; Davies A
Somat Cell Mol Genet; 1999 May; 25(3):147-57. PubMed ID: 11441534
[TBL] [Abstract][Full Text] [Related]
5. Expression of protectin (CD59) in human melanoma and its functional role in cell- and complement-mediated cytotoxicity.
Brasoveanu LI; Altomonte M; Gloghini A; Fonsatti E; Coral S; Gasparollo A; Montagner R; Cattarossi I; Simonelli C; Cattelan A
Int J Cancer; 1995 May; 61(4):548-56. PubMed ID: 7538980
[TBL] [Abstract][Full Text] [Related]
6. A monoclonal antibody that blocks the complement regulatory activity of guinea pig erythrocytes and characterization of the antigen involved as guinea pig decay-accelerating factor.
Okada N; Tanaka H; Takizawa H; Okada H
J Immunol; 1995 Jun; 154(11):6103-11. PubMed ID: 7538542
[TBL] [Abstract][Full Text] [Related]
7. CD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells.
Davies A; Simmons DL; Hale G; Harrison RA; Tighe H; Lachmann PJ; Waldmann H
J Exp Med; 1989 Sep; 170(3):637-54. PubMed ID: 2475570
[TBL] [Abstract][Full Text] [Related]
8. Expression of complement regulatory proteins [membrane cofactor protein (CD46), decay accelerating factor (CD55), and protectin (CD59)] in endometrial stressed cells.
Iborra A; Mayorga M; Llobet N; Martínez P
Cell Immunol; 2003 May; 223(1):46-51. PubMed ID: 12914757
[TBL] [Abstract][Full Text] [Related]
9. Epitope mapping of 10 monoclonal antibodies against the pig analogue of human membrane cofactor protein (MCP).
Pérez De La Lastra JM; Van Den Berg CW; Bullido R; Almazán F; Domínguez J; Llanes D; Morgan BP
Immunology; 1999 Apr; 96(4):663-70. PubMed ID: 10233756
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of paroxysmal nocturnal haemoglobinuria by phenotypic analysis of erythrocytes using two-colour flow cytometry with monoclonal antibodies to DAF and CD59/MACIF.
Shichishima T; Terasawa T; Saitoh Y; Hashimoto C; Ohto H; Maruyama Y
Br J Haematol; 1993 Oct; 85(2):378-86. PubMed ID: 7506570
[TBL] [Abstract][Full Text] [Related]
11. Role and regulation of pig CD59 and membrane cofactor protein/CD46 expressed on pig aortic endothelial cells.
van den Berg CW; Rix C; Hanna SM; Perez de la Lastra JM; Morgan BP
Transplantation; 2000 Aug; 70(4):667-73. PubMed ID: 10972227
[TBL] [Abstract][Full Text] [Related]
12. Expression of recombinant CD59 with an N-terminal peptide epitope facilitates analysis of residues contributing to its complement-inhibitory function.
Zhou Q; Zhao J; Hüsler T; Sims PJ
Mol Immunol; 1996 Oct; 33(14):1127-34. PubMed ID: 9047379
[TBL] [Abstract][Full Text] [Related]
13. Expression of recombinant transmembrane CD59 in paroxysmal nocturnal hemoglobinuria B cells confers resistance to human complement.
Rother RP; Rollins SA; Mennone J; Chodera A; Fidel SA; Bessler M; Hillmen P; Squinto SP
Blood; 1994 Oct; 84(8):2604-11. PubMed ID: 7522635
[TBL] [Abstract][Full Text] [Related]
14. Contribution of the N-linked carbohydrate of erythrocyte antigen CD59 to its complement-inhibitory activity.
Ninomiya H; Stewart BH; Rollins SA; Zhao J; Bothwell AL; Sims PJ
J Biol Chem; 1992 Apr; 267(12):8404-10. PubMed ID: 1373727
[TBL] [Abstract][Full Text] [Related]
15. Protease-modified erythrocytes: CD55 and CD59 deficient PNH-like cells.
Yuan FF; Bryant JA; Fletcher A
Immunol Cell Biol; 1995 Feb; 73(1):66-72. PubMed ID: 7539403
[TBL] [Abstract][Full Text] [Related]
16. A novel epitope of CD59 expressed by primitive human hematopoietic progenitors.
Simmons PJ; Zannettino AC; Harrison-Findik D; Swart B; Tomlinson S; Hill B; Javni JA
Exp Hematol; 2001 Dec; 29(12):1474-83. PubMed ID: 11750107
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a glycosyl-phosphatidylinositol anchor-deficient subline of Raji cells. An analysis of the functional importance of complement inhibitors on the Raji cell line.
Harris CL; Morgan BP
Immunology; 1995 Oct; 86(2):311-8. PubMed ID: 7490134
[TBL] [Abstract][Full Text] [Related]
18. Expression of complement regulatory proteins on human eggs and preimplantation embryos.
Fenichel P; Donzeau M; Cervoni F; Menezo Y; Hsi BL
Am J Reprod Immunol; 1995 Feb; 33(2):155-64. PubMed ID: 7544131
[TBL] [Abstract][Full Text] [Related]
19. Isolation and characterization of the complement-inhibiting protein CD59 antigen from platelet membranes.
Morgan BP
Biochem J; 1992 Mar; 282 ( Pt 2)(Pt 2):409-13. PubMed ID: 1372164
[TBL] [Abstract][Full Text] [Related]
20. The PIG-anchoring defect in NK lymphocytes of PNH patients.
Schubert J; Uciechowski P; Delany P; Tischler HJ; Kolanus W; Schmidt RE
Blood; 1990 Sep; 76(6):1181-7. PubMed ID: 1698101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
